Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs midazolam for sedation and analgesia during burn dressing changes
ChiCTR2100049325Phase 4Not yet recruiting
- Sponsor
- Jiangsu University Affiliated Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, midazolam and butorphanol in burn injury (2 arms), sponsored by Jiangsu University Affiliated Hospital. Primary endpoints: Sedation score and Pain score. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolambutorphanol
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR2100049325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049325.